![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
Reset all filters
01 1Zenji Pharmaceuticals (Suzhou) Ltd.
Reset all filters
01 1Leaders Bio Co., Ltd.
Reset all filters
01 1Meglumine
Reset all filters
01 1China
Registrant Name : Leaders Bio Co., Ltd.
Registration Date : 2018-07-21
Registration Number : 20180721-210-J-246
Manufacturer Name : Zenji Pharmaceuticals (Suzho...
Manufacturer Address : No.122, Xuqing Road, Xuguan Town, Suzhou, Jiangsu, China
A Meglumine Ioxitalamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Meglumine Ioxitalamate, including repackagers and relabelers. The FDA regulates Meglumine Ioxitalamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Meglumine Ioxitalamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Meglumine Ioxitalamate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Meglumine Ioxitalamate supplier is an individual or a company that provides Meglumine Ioxitalamate active pharmaceutical ingredient (API) or Meglumine Ioxitalamate finished formulations upon request. The Meglumine Ioxitalamate suppliers may include Meglumine Ioxitalamate API manufacturers, exporters, distributors and traders.
click here to find a list of Meglumine Ioxitalamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Meglumine Ioxitalamate Drug Master File in Korea (Meglumine Ioxitalamate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Meglumine Ioxitalamate. The MFDS reviews the Meglumine Ioxitalamate KDMF as part of the drug registration process and uses the information provided in the Meglumine Ioxitalamate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Meglumine Ioxitalamate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Meglumine Ioxitalamate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Meglumine Ioxitalamate suppliers with KDMF on PharmaCompass.
We have 1 companies offering Meglumine Ioxitalamate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?